Neurexin synaptic organizing proteins are central to a genetic risk pathway in neuropsychiatric disorders. Neurexins…
pthomsonJuly 7, 2023
Dr. Joseph Lau is working to develop the next generation of radiopharmaceuticals for both diagnostic…
pthomsonJuly 6, 2023
Children’s immature immune systems make them more susceptible to gut bacterial infections, and more and…
pthomsonJuly 6, 2023
In Canada, prostate cancer is the most common cancer affecting men (excluding non-melanoma skin cancers)…
pthomsonJuly 5, 2023
Drs. Khaled Abdelrahman (pictured) and Brian MacVicar at the Djavad Mowafaghian Centre for Brain Health…
pthomsonJuly 4, 2023
The BC-CfE is proud to announce Executive Director & Physician-in-Chief Dr. Julio Montaner is among the three…
pthomsonJuly 4, 2023
Michael Smith Health Research BC is excited to announce our 2024 suite of funding programs…
pthomsonJuly 4, 2023
In early November 2019, the Centre for Blood Research proudly presented ‘Breakfast with Bayer,’ a…
eabramovichApril 22, 2020
For myelodysplastic syndrome patients harbouring a particular genetic variant, lenalidomide is the drug of choice.…
eabramovichApril 21, 2020
Microbiome Insights is honoured to be featured in the 2020 Life Science Ready to Rocket…
eabramovichApril 21, 2020
The Prevention of Organ Failure (PROOF) Centre of Excellence is pleased to announce Dr. Scott…
eabramovichApril 21, 2020
In March, Vancouver-based biotech firm AbCellera Biologics Inc. became the first company in North America to receive…
eabramovichApril 20, 2020
Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that it initiated a research partnership with researchers…
eabramovichApril 20, 2020
The LSI’s Ninan Abraham, an expert on immunity to respiratory tract pathogens, is featured as…
eabramovichApril 17, 2020
Dr. Jacqueline Quandt (pictured) has been appointed to the role of Academic Director of the Vancouver Coastal…
eabramovichApril 16, 2020
